New developments in screening for genetic disease
Seashore, M.R.
Connecticut Medicine 41(3): 145-150
1977
ISSN/ISBN: 0010-6178 PMID: 319943 Document Number: 114780
Document emailed within 1 workday
Related Documents
Mallia, P.; ten Have, H. 2005: Applying theological developments to bioethical issues such as genetic screening Ethics and Medicine: a Christian Perspective on Issues in Bioethics 21(2): 95-107Tsukahara, T.; Kadota, R.L. 1977: Economic considerations in genetic screening programs for Tay-Sachs disease Progress in Clinical and Biological Research 18: 319-327
Wu, Y.; Nishio, H.; Lee, M.J.; Ayaki, H.; Hayashi, A.; Ooba, T.; Ogawa, T.; Sumino, K. 2000: Molecular genetic analysis and mutation screening of the VHL gene in a Japanese family with von Hippel-Lindau disease Kobe Journal of Medical Sciences 46(4): 147-153
Ausems, M.G.E.M.; Oosterwijk, J.C.; Nielsen, M.; Lolkema, M.P.; Hoogerbrugge, N.; Ligtenberg, M.J.L. 2019: Genetic testing in patients with cancer; new developments Nederlands Tijdschrift Voor Geneeskunde 163
Rosner, F. 1998: Judaism, genetic screening and genetic therapy Mount Sinai Journal of Medicine new York 65(5-6): 406-413
Wildhagen, M.F.; Christiaens, G.C.; Habbema, J.D. 1996: Serum screening in pregnant women for Down syndrome and open neural-tube defects; testing against the Health Council criteria for genetic screening Nederlands Tijdschrift Voor Geneeskunde 140(2): 85-89
Horton, W.A. 1978: Dwarfism--an overview. Recent developments in diagnostic and genetic concepts Journal of the Kansas Medical Society 79(2): 58-61
Mathevet, P.; Jacot-Guillarmod, M. 2015: Current developments in uterine cervical carcinoma prevention and screening Revue Medicale Suisse 11(492): 1999-2003
Brock, D.J. 1996: Cost effectiveness of antenatal screening for cystic fibrosis. Realistic cost must be established for genetic counselling in two step screening Bmj 312(7035): 908; Author Reply 910
Franco, E.; Syrjänen, K.; de Wolf, C.; Patnick, J.; Ferenczy, A.; McGoogan, E.; Bosch, X.; Singer, A.; Muñoz, N.; Meheus, A.; Monsonego, J. 1996: New developments in cervical cancer screening and prevention. Geneva, Switzerland, June 17-19 1996. Workshop Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 5(10): 853-856
Horváth, M.; Tímár, L.; Karcagi, V.; Czeizel, E. 1997: The importance of molecular genetic diagnosis of Martin-Bell disease in genetic counseling Orvosi Hetilap 138(9): 541-545
Tadokoro, M.; Machida, H.; Ohgushi, H. 2010: Genetic basis for skeletal disease. Stem cell therapy for genetic bone disorders Clinical Calcium 20(8): 1228-1235
Gera, Ián.; Vári, M. 2009: Genetic background of periodontitis. Part II. Genetic polymorphism in periodontal disease. A review of literature Fogorvosi Szemle 102(4): 131-140
Macedo, Aéa.M.; Machado, C.R.; Oliveira, R.P.; Pena, Sérgio.D.J. 2004: Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease Memorias do Instituto Oswaldo Cruz 99(1): 1-12
Smith, K.C. 2001: MSJAMA: genetic disease, genetic testing, and the clinician JAMA 285(1): 91
Gitzelmann, R. 1982: Rationales for genetic screening Progress in Clinical and Biological Research 103 Pt B: 425-436
Metcalfe, S.A.; Barlow-Stewart, K.; Delatycki, M.B.; Emery, J. 2007: Population genetic screening Australian Family Physician 36(10): 794-800
Schechter, D. 1983: Genetic screening in the workplace Occupational Health and Safety 52(4): 8-12
Rierson, L. 1992: The genetic screening of multifactorial disorders North Carolina Medical Journal 53(4): 178-179
Jegede, A.S. 2009: Culture and genetic screening in Africa Developing World Bioethics 9(3): 128-137